Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real-world comparison

Mar Tormo, Ariadna Pérez-Martínez, Marisa Calabuig, Juan Carlos Hernández-Boluda, Paula Amat, David Navarro, Carlos Solano
  • Mycoses, January 2018, Wiley
  • DOI: 10.1111/myc.12728
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: David Navarro